Assessment of the lymphocyte repertoire in relapsing-remitting multiple sclerosis patients treated with ocrelizumab: the ImmunoReMS study

被引：0
|
作者：
Esposito, Federica [1 ,2 ]
Ferre, Laura [1 ,2 ]
Mascia, Elisabetta [2 ]
Sorosina, Melissa [2 ]
Clarelli, Ferdinando [2 ]
Santoro, Silvia [2 ]
Giordano, Antonino [1 ,2 ]
Cannizzaro, Miryam [1 ,2 ]
Moiola, Lucia [1 ]
Martinelli, Vittorio [1 ]
Filippi, Massimo [3 ,4 ,5 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Div Neurosci, Lab Human Genet Neurol Disorders, INSPE, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Neurol & Neurorehabil Unit, Milan, Italy
[4] IRCCS San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit, INSPE, Milan, Italy
[5] Univ Vita Salute San Raffaele, Milan, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1285/1895
引用
收藏
页码：815 / 815
页数：1
相关论文
共 50 条
  • [21] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [22] Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab
    Doehler, N.
    Mueller, S.
    Vehoff, J.
    Galovic, M.
    Tettenborn, B.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 213
  • [23] Number Needed to Treat Analyses to Assess Clinical Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab or Ocrelizumab
    Comi, Giancarlo
    Alroughani, Raed
    Berkovich, Regina
    Limmroth, Volker
    Al Macdonell, Richard
    Moreau, Thibault
    Wiendl, Heinz
    van Wijmeersch, Bart
    Melanson, Maria
    Thangavelu, Karthinathan
    Freedman, Mark S.
    Boster, Aaron
    NEUROLOGY, 2017, 88
  • [24] Employment and cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data
    Wiendl, H.
    Benedict, R. H.
    Comi, G.
    Oreja-Guevara, C.
    Siva, A.
    Van Wijmeersch, B.
    Buffels, R.
    Kuenzel, T.
    Vermersch, P.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 676 - 677
  • [25] Comparing the Efficacy and Safety of Natalizumab and Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis and Spinal Lesions
    Huntemann, Niklas
    Mueller, Marc
    Masanneck, Lars
    Baumgart, Romy
    Axhausen, Franziska
    Wolff, Stephanie
    Kutsojannis, Bela
    Koelsche, Tristan
    Korsen, Melanie
    Pfeuffer, Steffen
    Meuth, Sven
    Pawlitzki, Marc
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 90 - 91
  • [26] A broad effect of ocrelizumab on the peripheral immune component in patients with early relapsing-remitting multiple sclerosis
    Garcia, A.
    Morille, J.
    Shah, S.
    Le Frere, F.
    Nicot, A.
    Berthelot, L.
    Wiertlewski, S.
    Gourraud, P. -A.
    Raposo, C.
    Bakdache, F.
    Buffels, R.
    Laplaud, D. -A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 593 - 594
  • [27] Ocrelizumab modifies circulating immune asset in relapsing-remitting multiple sclerosis subjects
    Abbadessa, Gianmarco
    Bruzzaniti, Sara
    Miele, Giuseppina
    Piemonte, Erica
    Signoriello, Elisabetta
    Lus, Giacomo
    Matarese, Giuseppe
    Galgani, Mario
    Bonavita, Simona
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 21 - 21
  • [28] Shorter infusion time of ocrelizumab: results from the ensemble plus study in patients with relapsing-remitting multiple sclerosis
    Brochet, B.
    Berger, T.
    Bermel, R.
    Freedman, M.
    Hartung, H. P.
    Holmoy, T.
    Killestein, J.
    Ross, A. Perrin
    Buffels, R.
    Garas, M.
    Kadner, K.
    Schneble, H. -M.
    Wang, Q.
    Nos, C.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 307 - 308
  • [29] Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-β
    Puissant-Lubrano, Benedicte
    Viala, Frederique
    Winterton, Peter
    Abbal, Michel
    Clanet, Michel
    Blancher, Antoine
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 193 (1-2) : 188 - 194
  • [30] Circulating lymphocyte levels and relationship with infection status in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta
    Giovannoni, Gavin
    Wiendl, Heinz
    Turner, Benjamin
    Umans, Kimberly
    Mokliatchouk, Oksana
    Castro-Borrero, Wanda
    Greenberg, Steven J.
    McCroskery, Peter
    Giannattasio, Giorgio
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (13) : 1725 - 1736
12345